Looking for a specific product?

Make a search for products & suppliers, articles & news.

Bionor Pharma's "Kick, Kill & Boost" Strategy Advances

Bionor Pharma ASA (OSE: BIONOR) announces that the Company has chosen romidepsin for the planned combination study with Vacc-4x, after considering various HDAC inhibitors (HDACi). Romidepsin is marketed in the US as Istodax® by Celgene Corporation Inc. 

The "Kick, Kill" study is planned to be conducted by the HIV research team at
Aarhus University Hospital, led by Prof. Lars Østergaard. Prof.  Østergaard
presented the background and expectations of the study at Bionor Pharma's
Capital Markets Day in June. 

 

To read more, please visit the Bionor Pharma website.

Associated companies:


Related news

Latest news

Alliance for offshore wind energy development, Southern Vietnam

Enterprize Energy is Joint Venturing with Renewable Energy Global Solutions, 

New Business Development Manager in Sweden

Mikael explained that when he first got in contact with Oglaend System,

New and innovative starter brackets for hollow concrete sections

Each bracket has a load capacity of up to 1000 kg,

TechnipFMC celebrates 45 years of enhancing the performance of the engineering industry in Spain

TechnipFMC recently commemorated the event with a celebration in Barcelona,

AKVA group to deliver new feed barge to Arctic Sea Farm

Local presence on Iceland and a good training program were critical factors why Arctic Sea Farm hf chose AKVA group as supplier.

World's fastest ROV? - Project ROST

Traditionally, all cleaning has been carried out from a workboat,

New regional manager takes the helm in key oil and gas markets for DNV GL

Elaborating on the differences in the energy markets which now lie under his new responsibilities in DNV GL,

DNV GL launches certification framework and recommended practice for Carbon Capture and Storage (CCS)

The recommended practice DNVGL-RP-F104 Design and operation of carbon dioxide pipelines, 

DNV GL launches new JDP to test biodegradable lubricants

The test programme will investigate such aspects as hydrodynamic oil film formation,